Ipsen S.A. (IPSEY) Investment Research Dashboard
About Ipsen S.A. (IPSEY) stock analysis
Get live IPSEY stock price $46.70, comprehensive Ipsen S.A. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time IPSEY stock data and investment insights.
Loading chart data...
Ipsen S.A. (IPSEY) Overview
Ipsen S.A. (IPSEY) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, IPSEY trades at $46.70 with a market capitalization of 61.75B . Over the past 52 weeks, IPSEY has traded between $30.05 and $51.10 , with the current price positioned at approximately 79% of this range . The stoc...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 61.75B
- Current price: $46.70
- 52-week range: $30.05 - $51.10
- P/E ratio: 15.72
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Ipsen S.A., a biopharmaceutical company, develops and commercializes medicines in the areas of oncology, rare disease, and neuroscience worldwide. Its oncology products include Somatuline for the treatment of neuroendocrine tumors and acromegaly; Cab...
Company Information
- CEO
- David Loew
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 5535
Contact Information
- Website
- https://www.ipsen.com
- Address
- 70 rue Balard
- Country
- FR
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 15.7)
✓ Lower volatility stock (Beta: 0.32) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Ipsen S.A. shareholders
- ⚠Market volatility can significantly impact stock price, especially for mid-cap stocks
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Ipsen S.A.
- ⚠Investors should consider how Ipsen S.A. fits within their overall portfolio allocation
Market Cap
61.75B
P/E Ratio (TTM)
15.72
Beta
0.32
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare IPSEY with peer companies:
- Price
- $0.00+0.00% (1D)
- Market cap
- 6.66K
- Price
- $17.33-4.06% (1D)
- Market cap
- 31.53B
- Price
- $17.84+2.41% (1D)
- Market cap
- 32.46B
- Price
- $4.92-1.31% (1D)
- Market cap
- 43.29B
- Price
- $175.38+13.76% (1D)
- Market cap
- 58.67B
- Price
- $167.51+2.63% (1D)
- Market cap
- 72.83B
- Price
- $32.96+2.15% (1D)
- Market cap
- 71.65B
- Price
- $32.60+4.52% (1D)
- Market cap
- 51.86B
- Price
- $142.43+1.95% (1D)
- Market cap
- 54.23B
- Price
- $21.56-0.28% (1D)
- Market cap
- 64.33B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
78/100 ⭐⭐⭐⭐⭐
- Overall
- +0.7%
- NYSE
- +0.6%
- NASDAQ
- +0.7%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +2.2% | +3.1% | +4.3% | 19.3 | 98/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.7% | +1.3% | +1.6% | 24.1 | 78/100⭐⭐⭐⭐⭐ |
| Communication Services | +1.4% | -0.7% | +2.9% | 22.2 | 74/100⭐⭐⭐⭐⭐ |
| Consumer Defensive | -0.2% | +1.8% | +0.7% | 29.7 | 64/100⭐⭐⭐⭐ |
| Basic Materials | +0.4% | +1.2% | -0.2% | 25.2 | 61/100⭐⭐⭐⭐ |
| Real Estate | -0.5% | +0.0% | -2.5% | 29.2 | 43/100⭐⭐⭐ |
| Energy | -2.1% | -3.7% | -4.1% | 19.1 | 39/100⭐⭐ |
| Utilities | -1.0% | +0.0% | -4.4% | 26.8 | 37/100⭐⭐ |
| Industrials | +0.6% | +0.4% | -9.9% | 30.1 | 23/100⭐ |
| Consumer Cyclical | +0.5% | -1.5% | -5.8% | 43.0 | 18/100⭐ |
| Technology | +0.6% | -1.6% | -7.2% | 40.7 | 15/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.